Related Experiment Video
Updated: Jun 8, 2026

Comparing the Effects of Electronic Cigarette Vapor and Cigarette Smoke in a Novel In Vivo Exposure System
Published on: May 24, 2017
Does breath carbon monoxide measure nicotine dependence?
Nestor D Kapusta1, Jakob Pietschnig, Paul L Plener
1Department of Psychoanalysis and Psychotherapy, Medical University of Vienna, Vienna, Austria. nestor.kapusta@meduniwien.ac.at
Exhaled carbon monoxide (CO) effectively identifies smokers but does not accurately measure nicotine dependence severity. This study shows CO is a good smoking status marker, not a nicotine dependence predictor.
Area of Science:
- Public Health
- Clinical Chemistry
- Addiction Medicine
Background:
- Nicotine dependence is a significant public health concern.
- Accurate assessment of smoking status and dependence is crucial for effective interventions.
- Exhaled carbon monoxide (CO) is a non-invasive biomarker of recent smoking.
Purpose of the Study:
- To evaluate exhaled carbon monoxide (CO) levels as a predictor of smoking heaviness and nicotine dependence.
- To determine the diagnostic accuracy of CO in differentiating smokers from non-smokers and varying levels of nicotine dependence.
Main Methods:
- A cross-sectional study of 1,870 Austrian male military conscripts.
- Assessment of nicotine dependence using the Heaviness of Smoking Index (HSI).
- Measurement of expired breath carbon monoxide (CO) levels and Receiver-Operating Characteristic (ROC) curve analysis.
Main Results:
- Exhaled CO levels effectively discriminate between smokers and non-smokers (AUC, sensitivity 95%, specificity 83% at ≥ 5.5 ppm).
- CO levels did not adequately discriminate between different severity levels of nicotine dependence.
- A CO cut-off of ≥ 5.5 ppm demonstrated optimal discrimination for smoking status.
Conclusions:
- Exhaled carbon monoxide is a valuable and practical biomarker for identifying current smoking status.
- CO levels are not a reliable indicator for assessing the severity of nicotine dependence.
- Further research may explore other biomarkers for nicotine dependence severity.
Related Concept Videos
Drugs Acting on Autonomic Ganglia: Stimulants
Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating sympathetic or...
Assessment of Diffusion and Perfusion
The Role of Diffusion in Respiration
Diffusion is the process by which molecules move from an area of higher concentration to an area of lower concentration. In the respiratory system, this principle...
CNS Depressants: Alcohol and Nicotine
Chemical Factors Affecting Respiration Centers
CO2 has a potent influence on respiration and is strictly regulated. Under...
Drug Dependence
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
Medical History

